|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||461.549 g/mol g·mol−1|
|3D model (JSmol)|
Bitolterol mesylate (Tornalate) is a short-acting β2 adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and COPD. In these disorders there is a narrowing of the airways (bronchi and their ramifications) that carry air to the lungs. Muscle spasm and inflammation within the bronchi get worse this narrowing. Bitolterol relaxes the smooth muscles present continuously around the bronchi and bronchioles facilitating the flow of air through them.
Bitolterol is a prodrug of colterol. It has a rapid onset of action (2–5 minutes) and may last up to 6–8 hours. The drug, alone or in co-administration with theophylline, doesn't show cardiotoxic effect.
|This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.|